With these key hires, Alpha Cognition is poised to advance its mission of improving the lives of patients and families ...
Alpha Cognition (ACOG) announced the strategic appointments of Jen Pesa, Vice President of Commercial; Jack Kelly, Head of Market Access; ...
Alpha Cognition Inc. (NASDAQ:ACOG) and China Medical System Holdings Limited announced an exclusive licensing agreement for ...
VANCOUVER, British Columbia & DALLAS, January 08, 2025--Alpha Cognition, Inc. (Nasdaq: ACOG) ("ACI" or the "Company"), a biopharmaceutical company developing novel therapeutics for debilitating ...
4d
Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
The agreement with China Medical System Holdings Limited is for the development, manufacturing, and commercialization of ...
Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.
Equiti, a leading global fintech, announced that it has received in-principle approval from the Securities and Commodities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback